Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the “3 + 7” induction regimen for acute myeloid leukemia-Reference-Cited by-同舟云学术

Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the “3 + 7” induction regimen for acute myeloid leukemia

Published:2015-11-17 Issue:12 Volume:90 Page:1159-1164
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Ofran Yishai¹²,Leiba Ronit³,Ganzel Chezi⁴,Saban Revital⁴,Gatt Moshe⁵,Ram Ron⁶,Arad Ariela⁷,Bulvik Shlomo⁷,Hellmann Ilana⁸,Gino-Moor Sharon⁹,Zuckerman Tsila¹²,Hoffman Ron¹²,Horowitz Netanel¹²,Lavi Noa¹²,Ringelstein Shimrit¹²,Henig Israel¹,Hayun Michal¹,Rowe Jacob M.¹²⁴

Affiliation:

1. Department of Hematology and Bone Marrow Transplantation; Rambam Health Care Campus; Haifa Israel

2. Bruce Rappaport Faculty of Medicine; Technion, Haifa, Israel, Israel Institute of Technology

3. Quality of Care Unit; Rambam Health Care Campus; Haifa Israel

4. Department of Hematology; Shaare Zedek Medical Center; Jerusalem Israel

5. Hematology Department; Hadassah Hebrew University Medical Center; Jerusalem Israel

6. Department of Hematology and bone marrow transplantation; Sourasky Medical Center, Tel Aviv University; Tel Aviv Israel

7. Department of Hematology; Sanz Medical Center - Laniado Hospital; Netanya Israel

8. Hematology department; Meir Medical Center; Kfar Saba Israel

9. Hematology Unit; Bnai-Zion Medical Center; Haifa Israel

Funder

Israel Cancer Association

Publisher

Wiley

Subject

Hematology

Reference30 articles.

1. Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Fey;Ann Oncol,2013

2. Acute myeloid leukemia;O'Donnell;J Natl Compr Canc Netw,2011

3. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood,2010

4. Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia;Liso;Haematologica,2000

5. Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: Long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group;Bertoli;Haematologica,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy;Frontiers in Oncology;2024-02-20

2. Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study;Leukemia Research;2022-08

3. Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia;Regenerative Biomaterials;2022-01-01

4. Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy;Haematologica;2021-11-11

5. The utility of day 14 bone marrow response assessment in patients undergoing acute myeloid leukemia induction: A single institution retrospective experience;Cancer Research, Statistics, and Treatment;2021